bevacizumab (Q413299)

From Wikidata
Jump to navigation Jump to search
pharmaceutical drug
  • 12-IGG1
  • RG-435
  • antiVEGF
  • R-435
  • Rhumab-VEGF
  • Avastin
edit
Language Label Description Also known as
English
bevacizumab
pharmaceutical drug
  • 12-IGG1
  • RG-435
  • antiVEGF
  • R-435
  • Rhumab-VEGF
  • Avastin

Statements

mass
149,000 dalton
1 reference
stated in
DrugBank
DrugBank ID
00112
chemical formula
C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄
0 references
medical condition treated
Commons category
Bevacizumab
0 references

Identifiers

HSDB ID
8080
1 reference
stated in
Hazardous Substances Data Bank
HSDB ID
8080
publication date
28 October 2019
title
Bevacizumab (English)
retrieved
10 May 2021
DrugBank ID
DB00112
0 references
CA PROP 65 ID
bevacizumab
0 references
DeCS ID
55974
0 references
electronic Essential Medicines List medicine ID
238
1 reference
reference URL
https://list.essentialmeds.org/medicines/238
title
eEML - Electronic Essential Medicines List (English)
retrieved
23 October 2021
Microsoft Academic ID
2777802072
0 references
2910640057
0 references
YSO ID
39032
subject named as
bevasitsumabi
bevacizumab
1 reference
stated in
YSO-Wikidata mapping project
retrieved
28 January 2022
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                Retrieved from "https://www.wikidata.org/w/index.php?title=Q413299&oldid=2190015651"